Nearly 10 years after Kara Kenan of North Carolina finished treatment for advanced breast cancer, her routine bloodwork revealed an increased level of an enzyme called alkaline phosphatase. Kenan's primary care doctor didn't think that was important, so he ordered no further tests.
Nearly 10 years after Kara Kenan of North Carolina finished treatment for advanced breast cancer, her routine bloodwork revealed an increased level of an enzyme called alkaline phosphatase.
Kenan's primary care doctor didn't think that was important, so he ordered no further tests.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Nearly 10 years after Kara Kenan of North Carolina finished treatment for advanced breast cancer, her routine bloodwork revealed an increased level of an enzyme called alkaline phosphatase. Kenan's primary care doctor didn't think that was important, so he ordered no further tests.
Open the app view to save this story, compare related coverage, and continue from the same source.